Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Daily News

Recognize and Enable Care for Post-MI Psychological Distress: AHA

L.A. McKeown

October 01, 2025

News Daily News

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

Michael O'Riordan

June 06, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

L.A. McKeown

May 23, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News SCAI 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

L.A. McKeown

May 21, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

Shelley Wood

November 23, 2022

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Advertisement

October 2025 Dispatch for the CV Team

Recognize and Enable Care for Post-MI Psychological Distress: AHA

Liberal Transfusion Strategy for Acute MI and Anemia Doesn’t Impact QoL

TCTMD’s Top 10 Most Popular Stories for April 2025

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

February 2025 Dispatch for the CV Team

Top Structural Heart News of 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

What’s Going to Be Hot at TCT 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content